Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate monotherapy extension study in newly diagnosed partial-onset seizures
RBR-93gkd4Phase 3Recruiting
- Sponsor
- Instituto de Neurologia de Curitiba
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of eslicarbazepine acetate in epilepsy and Focal onset seizure, sponsored by Instituto de Neurologia de Curitiba. Started Jan 2016; status: recruiting.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsyFocal onset seizure
Beyond the preview
Go deeper on RBR-93gkd4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-93gkd4.